Reporter – US
Latest From Eileen Francis
Colgate won’t provide full-year 2020 guidance even as the company reports 5.5% organic growth in the second quarter. Its sales in North America grew 24% on pandemic-related purchasing and price increases.
Macro factors that could hamper results include the economic recession caused by businesses’ reactions to novel coronavirus pandemic, the impact of COVID-19 on consumer buying trends and disruptions to supply chains.
Sanofi says slower sales after consumers stockpiled cold and cough products in Q1 combined with OTC Zantac removal US and Canada drove 8% drop in consumer health care sales in Q2 to $1.18bn. Xyzal allergy brand had stellar results in the US and worldwide sales grew 76.9%.
In NAD review on a challenge by S.C. Johnson, which markets Caldrea brand essentials oils, Young Living said because consumers are equally as likely to believe the products are therapeutic grade regardless of which image they saw in a survey demonstrates the claim doesn’t impact consumers’ perception of its products.
In separate assessments, US industry self-regulation group says SmileDirectClub and UK advertising regulator finds HiSmile didn’t have adequate supporting evidence for claims about speed of teeth whitening.
Susan Trent joined the subsidiary of Bio-Medical Research Ltd. in 2019 as senior VP and US general manager to market Innovo.. She'd previously worked with GlaxoSmithKline for more than 20 years and as an industry consultant.